Literature DB >> 24970787

Effects of glutathione S-transferase M1 and T1 deletions on epilepsy risk among a Tunisian population.

Chahra Chbili1, Fatma B'chir2, Maha Ben Fredj3, Bochra-Nourhène Saguem3, Sana Ben Amor4, Sofiene Ben Ammou4, Saad Saguem5.   

Abstract

Glutathione-S-transferases enzymes are involved in the detoxification of several endogenous and exogenous substances. In this present study, we evaluated the effects of two glutathione-S-transferase polymorphisms, (GSTM1 and GSTT1) on epilepsy risk susceptibility in a Tunisian population. These polymorphisms were analyzed in 229 healthy subjects and 98 patients with epilepsy, using a polymerase chain reaction (PCR). Odds ratio (ORs) was used for analyzing results. The study results demonstrated that individuals with the GSTM1 null genotype were at an increased risk of developing epilepsy [OR=3.80, 95% confidence interval (CI) (2.15-4.78)], whereas no significant effects were observed between individuals with GSTT1 null genotype and epilepsy risk [OR=1.15, 95% CI (0.62-2.12)]. These genotyping finding revealed that the absence of GSTM1 activity could be contributor factor for the development of epilepsy disease.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epilepsy-genetic polymorphisms; Glutathione-S-transferase M1; Glutathione-S-transferase T1

Mesh:

Substances:

Year:  2014        PMID: 24970787     DOI: 10.1016/j.eplepsyres.2014.05.009

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  7 in total

1.  Glutathione-S-Transferase Deletions and Non-arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Wencui Wan; Tao Peng; Xuemin Jin; Qiuming Li; Fengyan Zhang; Guangying Zheng; Yong Lv; Guangming Wan; Yu Zhu
Journal:  Mol Neurobiol       Date:  2015-05-20       Impact factor: 5.590

2.  Lack of Association of Generic Brittle Status with Genetics and Physiologic Measures in Patients with Epilepsy.

Authors:  Sharmila Das; Dong Guo; Xiaohui Jiang; Wenlei Jiang; Yan Shu; Tricia Y Ting; James E Polli
Journal:  Pharm Res       Date:  2020-02-26       Impact factor: 4.200

3.  Do GSTM1 and GSTT1 polymorphisms influence the risk of developing mitochondrial diseases in a Tunisian population?

Authors:  Raouia Ghorbel; Ghada Ben Salah; Rania Ghorbel; Afif Ben Mahmoud; Imen Chamkha; Emna Mkaouar-Rebai; Leila Ammar-Keskes; Faiza Fakhfakh
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-12       Impact factor: 4.223

4.  Glutathione S-transferase M1 and T1 polymorphisms and the risk of mild hepatotoxicity induced by carbamazepine in a tunisian population study.

Authors:  Chahra Chbili; Anis Hassine; Neila Fathallah; Manel Nouira; Salma Naija; Sofiene Ben Ammou; Saad Saguem
Journal:  BMC Neurol       Date:  2018-03-09       Impact factor: 2.474

Review 5.  Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases.

Authors:  Nerino Allocati; Michele Masulli; Carmine Di Ilio; Luca Federici
Journal:  Oncogenesis       Date:  2018-01-24       Impact factor: 7.485

6.  AS3MT Polymorphism: A Risk Factor for Epilepsy Susceptibility and Adverse Drug Reactions to Valproic Acid and Oxcarbazepine Treatment in Children From South China.

Authors:  Xiaomei Fan; Yuna Chen; Jieluan Lu; Wenzhou Li; Xi Li; Huijuan Guo; Qing Chen; Yanxia Yang; Hanbing Xia
Journal:  Front Neurosci       Date:  2021-11-26       Impact factor: 4.677

7.  Glutathione S-Transferase Polymorphisms and Clinical Characteristics in Autism Spectrum Disorders.

Authors:  Vanja Mandic-Maravic; Marija Mitkovic-Voncina; Marija Pljesa-Ercegovac; Ana Savic-Radojevic; Miroslav Djordjevic; Marko Ercegovac; Tatjana Pekmezovic; Tatjana Simic; Milica Pejovic-Milovancevic
Journal:  Front Psychiatry       Date:  2021-06-25       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.